Clinical and histopathology features to predict EGFR mutation of lung adenocarcinoma in Aceh Province, Indonesia

被引：0
|
作者：
Andriansyah, Vikri [1 ]
Yanti, Budi [2 ,3 ]
Ismida, Fitri Dewi [4 ]
Silvalila, Meilya [5 ]
机构：
[1] Univ Syiah Kuala, Sch Med, Pulmonol & Resp Med, Banda Aceh, Indonesia
[2] Univ Syiah Kuala, Sch Med, Dept Pulmonol & Resp Med, Banda Aceh, Indonesia
[3] Univ Syiah Kuala, Zainoel Abidin Teaching Hosp, Dept Pulmonol & Resp Med, Banda Aceh, Indonesia
[4] Univ Syiah Kuala, Sch Med, Dept Pathol Anat, Banda Aceh, Indonesia
[5] Univ Syiah Kuala, Sch Med, Dept Emergency Med, Banda Aceh, Indonesia
来源：
RESPIROLOGY | 2024年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
AP02-018
引用
收藏
页码：80 / 80
页数：1
相关论文
共 50 条
  • [21] Clinicopathologic and Prognostic Features of Early Resected Lung Adenocarcinoma Characterized with Uncommon EGFR Mutation
    Li, S.
    She, Y.
    Hou, L.
    Zhao, D.
    Chen, C.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S201 - S201
  • [22] Heterogeneity of the EGFR / KRAS Gene Mutation in Multifocal Lung Adenocarcinoma and the Clinical Significance
    Li, Lin
    Zhang, Susu
    Dai, Hongshuang
    Ying, Jianming
    Gao, Yanning
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S511 - S512
  • [23] Association of Omics Features with Histopathology Patterns in Lung Adenocarcinoma
    Yu, Kun-Hsing
    Berry, Gerald J.
    Rubin, Daniel L.
    Re, Christopher
    Altman, Russ B.
    Snyder, Michael
    CELL SYSTEMS, 2017, 5 (06) : 620 - +
  • [24] HOMOGENEITY OF EGFR MUTATION IN PATIENTS WITH RESECTED ADENOCARCINOMA OF THE LUNG
    Chi, L. K.
    Kwan, L. Y.
    Fai, T. K.
    Tong, J.
    Wu, C.
    Hsin, M.
    Chung, E.
    Wong, C.
    Kam, T. M. S.
    ANNALS OF ONCOLOGY, 2012, 23 : 137 - 137
  • [25] EGFR MUTATION TESTING IN SAUDI ARABIAN LUNG ADENOCARCINOMA
    Al-Dayel, Fouad H.
    Al Husaini, Hamad
    Tulbah, Asma
    Bavi, Prashant
    Abalkhail, Halah
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1254 - S1254
  • [26] EGFR mutation, smoking, and gender in advanced lung adenocarcinoma
    Tseng, Chien-Hua
    Chiang, Chun-Ju
    Tseng, Jeng-Sen
    Yang, Tsung-Ying
    Hsu, Kuo-Hsuan
    Chen, Kun-Chieh
    Wang, Chih-Liang
    Chen, Chih-Yi
    Yen, Sang-Hue
    Tsai, Chun-Ming
    Huang, Ming-Shyan
    Ho, Chao-Chi
    Yu, Chong-Jen
    Tsai, Ying-Huang
    Chen, Jin-Shing
    Chou, Teh-Ying
    Tsai, Ming-Hsun
    Chen, Hsuan-Yu
    Su, Kang-Yi
    Chen, Jeremy J. W.
    Chen, Huei-Wen
    Yu, Sung-Liang
    Liu, Tsang-Wu
    Chang, Gee-Chen
    ONCOTARGET, 2017, 8 (58) : 98384 - 98393
  • [27] Detection of an EGFR mutation in cytological specimens of lung adenocarcinoma
    Mohar, B.
    Jezek, S. Smojver
    Molek, K. Rajkovic
    Stemberger, C.
    Kurpis, M.
    Kupanovac, Z.
    Samarzija, M.
    Jonjic, N.
    Grahovac, B.
    CYTOPATHOLOGY, 2016, 27 (06) : 444 - 451
  • [28] Lung adenocarcinoma with concomitant EGFR mutation and ALK rearrangement
    Caliez, J.
    Monnet, I.
    Pujals, A.
    Rousseau-Bussac, G.
    Jabot, L.
    Boudjemaa, A.
    Leroy, K.
    Chouaid, C.
    REVUE DES MALADIES RESPIRATOIRES, 2017, 34 (05) : 576 - 580
  • [29] Accuracy and clinical influence of plasma EGFR mutation detection in management of advanced lung adenocarcinoma
    Ma, Meili
    Shi, Chunlei
    Qian, Jialin
    Han, Baohui
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (09): : 9559 - 9566
  • [30] The clinical outcome of stage I lung adenocarcinoma patients with or without activating EGFR mutation
    Fang, Yueh-Fu
    CANCER RESEARCH, 2017, 77
12345